A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
Clinical trial NCT05035836 · RECRUITING
Trial details
- NCT number
- NCT05035836
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2028-12-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.